Recommendations for the safe implementation of intravenous administration of mesenchymal stromal cells
Mesenchymal stromal cells (MSCs) are immunosuppressive, inflammation-reducing, and fibrosis-modifying cells that are currently being used for a variety of diseases. In this context, the transvenous administration of MSCs must be performed correctly under controlled standards. To support clinical pra...
Saved in:
| Main Authors: | Shuji Terai, Sachiko Ezoe, Kyosuke Mano, Yumi Matsuzaki, Yoji Sato, Kenichi Yamahara, Hideyuki Okano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Regenerative Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320425000240 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mesenchymal stromal cells from people with osteoporosis are fewer, and defective in both osteogenic and adipogenic capacity
by: Féaron C. Cassidy, et al.
Published: (2024-06-01) -
Mesenchymal Stem/Stromal Cells Microencapsulation for Cell Therapy
by: Sharaf Eldeen M. Abbas, et al.
Published: (2025-01-01) -
Mesenchymal stromal cells 2.0: thinking outside the box
by: Gabrielle A. Mandl, et al.
Published: (2025-08-01) -
Multipotent mesenchymal stromal cell therapy for a neonate with congenital diaphragmatic hernia and adhesive small bowel obstruction
by: Şükran Yıldırım, et al.
Published: (2024-11-01) -
Immunomodulatory interactions between mesenchymal stromal/stem cells and immune cells in psoriasis: therapeutic potential and challenges
by: Mohammadreza Dashti, et al.
Published: (2025-05-01)